Exposure to thiopurine drugs through breast milk is low based on metabolite concentrations in mother‐infant pairs

Abstract

The data suggest that azathioprine may be 'safe' during breastfeeding in patients with the wild-type TPMT genotype ( approximately 90% of caucasian patients) taking 'normal' doses.